OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Amazon vs. Costco: Which Stock Is a Better Buy?

Amazon vs. Costco: Which Stock Is a Better Buy?

Cross Staff Loads Up on 289,000 Shares of AKRE

Cross Staff Loads Up on 289,000 Shares of AKRE

Prediction: This Artificial Intelligence (AI) Stock Will Join Nvidia, Apple, and Alphabet in the $3 Trillion Club Before 2028

The billion-dollar infrastructure deals powering the AI boom

AI Boom May Be Creating Hidden Risks In Housing Market

Cisco’s Secure AI Factory Links Sovereign Data Push To Valuation Story

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Dow Jones Futures Fall After Market Rallies Into Fed Rate Hike; AMD, Snap Are Key Movers

February 1, 2023

Stocks rallied into the Fed rate hike decision, amid big earnings and other news. AMD, Snap were key movers late. Read More...

3rdPartyFeeds • News

: Who is Mukesh Ambani? He is now Asia’s richest person after Adani stocks tumble

February 1, 2023

Mukesh Ambani overtook Gautam Adani as India’s richest man on Wednesday as the fallout from a short seller report into the Adani Group continues to erase...

3rdPartyFeeds • News

Dow Jones Newswires: GSK posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businesses

February 1, 2023

The British pharma major UK:GSK GSK reported net profit of 1.50 billion pounds in the fourth quarter. Read More...

3rdPartyFeeds • News

Dow Jones Newswires: BBVA launches new share buybacks after $1.72 billion profit slightly beats forecasts

February 1, 2023

The Spanish bank said Wednesday that net profit in the three months to the end of December was 1.58 billion euros ($1.72 billion), up from EUR1.34 billion in...

3rdPartyFeeds • News

Dow Jones Newswires: Novartis posts lower sales and profit on generic competition, but boosts 2022 dividend

February 1, 2023

The Swiss pharma major posted net profit of $1.47 billion, down from $16.31 billion the year prior, when it benefited from the sale of its investment in Roche...

3rdPartyFeeds • News

The Ratings Game: AMD results may have given Wall Street sigh of relief, but they’re still a ‘mixed bag’ because of data-center weakness

February 1, 2023

AMD may have unleashed a collective sigh of relief on Wall Street with its results, but the data-center weakness makes them just "decent." Read More...

3rdPartyFeeds

What’s behind the job cuts in Big Tech?

February 1, 2023

This is an audio transcript of the Behind the Money podcast episode: ‘What’s behind the job cuts in Big Tech?’Michela Tindera Hey, everyone. Before we start...

3rdPartyFeeds • News

The Moneyist: My mother asked me to return my inheritance so she could give money to my brother, who is an addict. What should I have done?

February 1, 2023

‘I’ve suffered with my own financial and family problems for a long, long time.’
Read More...

3rdPartyFeeds

YouTube Shorts takes on TikTok in battle for younger users

February 1, 2023

Older videos platform introduces financial schemes to lure new content creators amid a slowdown in digital advertising Read More...

3rdPartyFeeds • News

: ‘Recession is underway’: Home builders expect single-family starts to fall further before recovering in the second half of this year

January 31, 2023

Home builders are expecting a little more pain before business improves.
Read More...

Previous 1 … 1,656 1,657 1,658 1,659 1,660 … 8,454 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.